An evaluation of a cardiac rehabilitation programme based on the internet

Evaluation of an interactive web-based cardiac rehabilitation programme in terms of the programme's effectiveness and acceptability in patients with angina

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN90110503

Enrollment

Registered

2008-08-07

Start date

2008-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina Circulatory System Angina pectoris

Interventions

Cardiac rehabilitation is an intervention for patients with coronary heart disease to achieve their optimal physical, emotional, social and vocational status. Typically cardiac rehabilitation programm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients anticipated to be aged from 45 to 70 years, either sex 2. A history of stable angina 3. Undergone coronary angioplasty treatment 4. Fluent in English 5. No prior cardiac rehabilitation in the previous year 6. Regular access to the internet

Exclusion criteria

Exclusion criteria: 1. Severely anxious or suffering from depression 2. Experiencing unstable angina 3. Significant cardiac arrhythmia 4. Co-morbidities which prevent physical activity 5. Any cardiac rehabilitation treatment in the previous year

Design outcomes

Primary

Measure	Time frame
The primary outcome measure is the assessment of physical activity. Physical activity will be measured using a ?SenseWear Pro3 Armband?. This physical activity monitor is an armband which will be used to assess participants' walking activity. Participants will be required to wear the armband on three separate occasions: 1. For a period of one week, before randomisation 2. For a period of one week, 6 weeks after randomisation 3. For a period of one week, at a 6 month follow-up	—

Measure

Time frame

The primary outcome measure is the assessment of physical activity. Physical activity will be measured using a ?SenseWear Pro3 Armband?. This physical activity monitor is an armband which will be used to assess participants' walking activity. Participants will be required to wear the armband on three separate occasions: 1. For a period of one week, before randomisation 2. For a period of one week, 6 weeks after randomisation 3. For a period of one week, at a 6 month follow-up

—

Secondary

Measure	Time frame
Secondary outcome measures include measuring: 1. Body fat 2. Weight 3. Blood pressure 4. Dietary intake, measured using the Dietary Instrument for Nutrition Education (DINE) 5. Patients' level of anxiety and depression, measured using Hospital Anxiety and Depression Scale (HADS) Other outcome measures include: 6. Assessing patients' perceived health status, measured with the Seattle Angina Questionnaire 7. Ability to interpret their illness positively, measured using the Silver Lining Questionnaire (SLQ) 8. Quality of life, measured using the MAC Quality of Life Scale 9. Self efficacy, measured using the Generalised Self Efficacy Scale 10. Healthcare costs (sub-scale taken from a larger questionnaire) Further, patients' attitudes and experiences of the programme will be explored using qualitative interviews. All secondary outcome measures will be taken at baseline, 6 weeks and 6 months after randomisation.	—

Measure

Time frame

Secondary outcome measures include measuring: 1. Body fat 2. Weight 3. Blood pressure 4. Dietary intake, measured using the Dietary Instrument for Nutrition Education (DINE) 5. Patients' level of anxiety and depression, measured using Hospital Anxiety and Depression Scale (HADS) Other outcome measures include: 6. Assessing patients' perceived health status, measured with the Seattle Angina Questionnaire 7. Ability to interpret their illness positively, measured using the Silver Lining Questionnaire (SLQ) 8. Quality of life, measured using the MAC Quality of Life Scale 9. Self efficacy, measured using the Generalised Self Efficacy Scale 10. Healthcare costs (sub-scale taken from a larger questionnaire) Further, patients' attitudes and experiences of the programme will be explored using qualitative interviews. All secondary outcome measures will be taken at baseline, 6 weeks and 6 months after randomisation.

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026